Primary del 17 chronic lymphocytic leukaemia lymphocytes are hypersensitive to dasatinibin vitro
Author:
Publisher
Wiley
Subject
Hematology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2009.07814.x/fullpdf
Reference10 articles.
1. Imatinib sensitizes CLL lymphocytes to chlorambucil;Aloyz;Leukemia,2004
2. Dasatinib sensitizes primary chronic lymphocytic leukaemia lymphocytes to chlorambucil and fludarabine in vitro;Amrein;British Journal of Haematology,2008
3. Dasatinib Has Activity in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL/SLL), a Phase II Trial;Amrein;Blood,2008
4. Chronic lymphocytic leukemia B cells contain anomalous Lyn tyrosine kinase, a putative contribution to defective apoptosis;Contri;Journal of Clinical Investigation,2005
5. Chronic lymphocytic leukaemia: the nature of the leukaemic cell;Hamblin;Blood Reviews,1997
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Combined chronic myeloid leukaemia and chronic lymphocytic leukaemia in five patients, including one with 17p deletion;Internal Medicine Journal;2021-04
2. Metabolic rewiring beyond Warburg in chronic lymphocytic leukemia: How much do we actually know?;Critical Reviews in Oncology/Hematology;2019-02
3. Ibrutinib Resistance Is Reduced by an Inhibitor of Fatty Acid Oxidation in Primary CLL Lymphocytes;Frontiers in Oncology;2018-09-26
4. The phosphatidylinositol-3 kinase I inhibitor BKM120 induces cell death in B-chronic lymphocytic leukemia cellsin vitro;International Journal of Cancer;2013-01-15
5. Protein kinases: emerging therapeutic targets in chronic lymphocytic leukemia;Expert Opinion on Investigational Drugs;2012-03-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3